Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
8.05-0.11 (-1.35%)
At close: 04:00PM EST
8.04 -0.01 (-0.12%)
After hours: 07:59PM EST
Advertisement
Full screen
Loading interactive chart...
  • Motley Fool

    2 Popular Healthcare Stocks I'd Avoid at All Costs

    When it comes to healthcare companies, sometimes it pays to steer clear of crowd favorites. Today, I'll be weighing in on two healthcare stocks that I plan to avoid for the foreseeable future. The generic drugmaker Teva Pharmaceuticals (NYSE: TEVA) is a risky stock that's easy to mistake for a stalwart.

  • Motley Fool

    5 Warren Buffett Stocks Are Screaming Buys in December

    Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Based on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities.

  • Business Wire

    Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S.

    TEL AVIV & PARSIPPANY, N.J., December 01, 2021--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of Epiduo®1 Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the United States.

Advertisement
Advertisement